More fundamental issues in diabetic ketoacidosis
Sir, Among the questions posed to the trainees 1 one of the issues which should have been raised was their perception of what the 'end point' should be in the management of diabetic ketoacidosis (DKA). Fourteen years ago that end point was defined, by one group, as 'normalization of blood hydroxybutyrate concentrations' 2 and characterized, more recently, by the observation that betahydroxybutyrate (B-OHB) is oxidized to acetoacetate 'when acidosis resolves with treatment'. 3 Furthermore, the fact that B-OHB is the most abundant ketone body in DKA 4 justifies the recommendation made by the American Diabetes Association that this is the parameter which should be used for monitoring of this disorder, 5 especially because, for detection of DKA, B-OHB is 98.1% sensitive, and has superior specificity (78.6 vs. 35.1%) to urine dipstick for measurement of ketones. 6 The strategy of B-OHB monitoring would also be more representative of ketone status than monitoring of bicarbonate status given the fact that DKA-related acid-base status is also influenced, to a significant (P < 0.001) degree, by non-ketone anions such as D-lactate. 7 From the point of view of management of the 'recovery' phase of DKA (when blood glucose falls below 14 mmol/l), an important observation was that the fall in total ketone bodies was significantly (P < 0.05) greater in patients receiving a 10% dextrose infusion concurrently with their intravenous insulin infusion than in counterparts receiving a 5% dextrose infusion concurrently with a lessintensive intravenous insulin infusion regimen. 8 In its own right, that observation should have prompted the investigators to inquire whether the respondents would manage the recovery phase of DKA with 10% dextrose (so as to allow the fixed-rate intravenous insulin infusion to be continued until ketosis has resolved) 9 or whether they would resort to 5% dextrose infusion (with concurrent sliding scale insulin) 'until food by mouth is possible', as recommended by the latest edition of what is arguably the trainees' most popular handbook of medicine. 10 
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